Y-mAbs Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Y-mAbs Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$0.48 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-01
- Y-mAbs Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.48.
- Y-mAbs Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.82.
- Y-mAbs Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$1.01.
- Y-mAbs Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.66.
- Y-mAbs Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.97.
- Y-mAbs Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$2.30.
- Y-mAbs Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.50.
- Y-mAbs Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.99.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$0.48 10-K · filed 2021-03-01 | -$1.31 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.32 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.97 10-K · filed 2021-03-01 |
| 2020-09-30 | -$0.82 10-K · filed 2021-03-01 | -$1.83 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$2.49 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$1.01 10-K · filed 2021-03-01 | -$1.67 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | -$0.66 10-K · filed 2021-03-01 | |||
| 2019-12-31 | -$0.60 10-K · filed 2021-03-01 | -$2.30 10-K · filed 2021-03-01 | ||
| 2019-09-30 | -$0.70 10-K · filed 2021-03-01 | -$1.69 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$0.53 10-K · filed 2021-03-01 | -$0.99 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$0.47 10-K · filed 2021-03-01 | |||
| 2018-12-31 | -$0.42 10-K · filed 2020-03-12 | -$1.50 10-K · filed 2020-03-12 | ||
| 2018-09-30 | -$0.42 10-K · filed 2020-03-12 | -$1.08 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | -$0.38 10-K · filed 2020-03-12 | -$0.66 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$0.28 10-K · filed 2020-03-12 | |||
| 2017-12-31 | -$0.44 10-K · filed 2019-03-22 | -$0.99 10-K · filed 2019-03-22 | ||
| 2017-09-30 | -$0.21 10-K · filed 2019-03-22 | -$0.56 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$0.18 10-K · filed 2019-03-22 | |||
| 2017-03-31 | -$0.16 10-K · filed 2019-03-22 |